STAT - Reporting from the frontiers of health and medicine

Health

Health

By Mona Gable

Biotech

Politics Pharma panics as Washington pushes to bring drug manufacturing back to the U.S.
Business ‘One thing cancer patients don’t generally have is time’: New cancer research leader brings urgency to Sanofi
First Opinion Biopharma companies are spreading misinformation — and taking advantage of it
First Opinion Hospitals are busier than ever — and going out of business
Biotech Argenx antibody drug improves symptoms in patients with myasthenia gravis

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

Startup Spotlight: Aiming to speed precision cancer therapies to children
Up and down the ladder: The latest comings and goings
Pharmalittle: Merck enters Covid-19 vaccine race; pharma alarmed by push for U.S.-only supply chain

Exclusive

Special Report

Special Report

Health

Health

By Gabrielle Glaser

Politics

Health He experienced a severe reaction to Moderna’s Covid-19 vaccine candidate. He’s still a believer
Biotech Merck leaps into Covid-19 vaccine race, aiming to test two different candidates this year
In the Lab ‘It’s something I have never seen’: How the Covid-19 virus hijacks cells
Health The Covid-19 Tracker
Politics Pharma panics as Washington pushes to bring drug manufacturing back to the U.S.
First Opinion When bubonic plague hit France in 1720, officials dithered. Sound familiar?
Health As Covid-19 tears through Navajo Nation, young people step up to protect their elders
Health Covid-19 study details benefits of treatment with remdesivir, and also its limitations